Blanco-Morales EA, Bravo-Ferrer Acosta JM, Rubio Romero E, Gil González E, Gantes Pedraza MÁ. [Glucocorticoids in rheumatoid arthritis: almost always or hardly ever?].
ACTA ACUST UNITED AC 2011;
7:407-11. [PMID:
22078702 DOI:
10.1016/j.reuma.2011.01.008]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2010] [Revised: 01/09/2011] [Accepted: 01/19/2011] [Indexed: 12/28/2022]
Abstract
The use of glucocorticoids in rheumatoid arthritis has been the source of frequent debate in the last decades. There is evidence on its anti-inflammatory capacity and its power to decrease radiologic progression, particularly if used in recent onset rheumatoid arthritis. However, there are still some voices questioning its use. Their arguments are its potential side-effects, especially when the glucocorticoids are used in high doses and/or for extended periods of time. In this review, we will try to summarize the evidence regarding this issue, from the beginning of the discussion in the fifties to the last releases.
Collapse